Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Liver Cirrhosis
• Liver Fibrosis
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Corewell Health East | Conditions: Fatty Liver Disease, Fibrosis, Liver | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-09-27